Saturday, January 29, 2005 6:50:26 PM
http://www.forbes.com/forbes/2004/0524/182.html
http://www.forbes.com/search/results.jhtml?MT=cytrx+corp.&sort=&aname=&author=&date=....
http://www.hoovers.com/cytrx/--ID__15904--/free-co-factsheet.xhtml?cm_ven=PAID&cm_cat=BUS&cm....
Latest News:
http://www.hoovers.com/cytrx/--ID__15904,Name__CytRx,Ticker__CYTR--/free-co-news-list.xhtml
________________________________________________________________
Comments from DewDiligence on IHUB:
Listed & Nasdaq / Biotechs / Hot Biotechs (HOTBIO)
Posted by: DewDiligence
In reply to: PowerPole who wrote msg# 2649 Date:1/29/2005 11:45:46 AM
Post #of 2651
Re: CYTR
This article from Forbes provides some background on the company and CEO:
#msg-4073074
You can call the Massachusetts Attorney General’s office for info about the state’s lawsuit against CYTR for attempting to usurp state (U Mass. Medical Center) assets.
Caveat emptor if you decide to go ahead on this one. Regards, Dew
________________________________________________________________
________________________________________________________________
PROS:
So far we have one analyst setting a 12 month price target of $7.00
They do have a number of interesting things in their pipeline. (That a number of other companies are researching also, and being first to the finish line is all important).
Any FDA fast track approval for Phase II or III will surely be a positive for pps.
The same goes for being acquired by another company.
They have had some good press about their drug Iroxanadine lately.
--------------------------------------------------------
CONS:
A CEO that's "Not in it for the money" and whose ethics are in question...(I need further research on his "ethics").
A Nobel Prize winning scientist that one journalist paints as having a wild side...IMO A lot of brilliant people have a wild side...
PR's in Barron's that are "paid for".
Good news one day, news of share dilution the next.
Lawsuits against them by the Massachusetts Attorney General’s office. (I haven't confirmed that yet).
The company has lost $81 million since it's inception (also not confirmed).
________________________________________________________________
________________________________________________________________
As DewDiligence said "Caveat emptor"--Buyer Beware!
I am not coming to any conclusions yet, my DD is not yet done.
I just thought I'd give you all something to look at until I post my conclusions. Please do your own DD and make a purchase of any stock based on your own conclusions, not by what someone posts on a message board.
Comments anyone?
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM